R.A. 7719 “National Blood Services Act of 1994”

R.A. 1517

An act regulating the collection, processing, and sale of human blood, and the establishment and operation of blood banks and blood processing laboratories

R.A. 1517

Blood Banking Law of 1956

June 16, 1956

When was R.A. 1517 approved?

7

How many sections does R.A. 1517 have?

R.A. 7719

An act promoting voluntary blood donation, providing for an adequate supply of safe blood, regulating blood banks, and providing penalties for violation thereof

R.A. 7719

National Blood Services Act of 1994

May 5, 1994

When was R.A. 7719 approved?

15

How many sections does R.A. 7719 have?

Section 1

Title

Section 2

Declaration of Policy

Section 3

Definition of Terms

Blood/blood product

Section 3 | Definition of Terms

Refers to human blood, processed or unprocessed and includes blood components, its products, and derivatives.

Blood bank/center

Section 3 | Definition of Terms

A laboratory or institution with the capability to recruit and screen blood donors, collect, process, store, transport and issue blood for transfusion and provide information and/or education on blood transfusion transmissible diseases;

Commercial blood bank

Section 3 | Definition of Terms

A blood bank that exists for profit

Hospital-based blood bank

Section 3 | Definition of Terms

A blood bank which is located within the premises of a hospital and can perform compatibility testing of blood

Blood collection unit

Section 3 | Definition of Terms

Institution or facility duly

authorized by the DOH to recruit and screen donors and collect blood

Voluntary blood donor

Section 3 | Definition of Terms

One who donates blood on one's own volition or initiative and without monetary compensation

Department

Section 3 | Definition of Terms

the Department of Health

Blood transfusion transmissible diseases

Section 3 | Definition of Terms

Diseases which may be transmitted as a result of blood transfusion,

including AIDS, Hepatitis-B, Malaria and Syphilis

Secretary of Health

Section 3 | Definition of Terms

The Secretary of Health or any other person to whom the Secretary delegates the responsibility of carrying out the provisions of this Act

Walking blood donor

Section 3 | Definition of Terms

An individual included in the list of qualified voluntary blood donors, who is ready ot donate blood when needed in his/her community.

450

63

Blood collection bags must have:

(?) mL of Blood

(?) mL of Anticoagulant

Blood products

Refer to therapeutic substances derived from whole blood or plasma and are also called the blood components.

Fresh whole blood

Blood Products

Blood collected within 24

hours.

Stored in a blood bag with an appropriate anticoagulant.

Provides RBCs, plasma, and platelet.

After 48 hours, it is called whole blood (WB) and it contains the red cells and plasma components of donor blood.

Packed red blood cells

Blood Products

AKA red cell concentrate,

Concentrated RBCs, or plasma reduced blood are prepared by allowing the blood to separate under the influence of gravity

Washed red cells

Blood Products

Red cells washed with 0.9% sterile isotonic saline using a manual method to remove majority of plasma proteins, antibodies and electrolytes.

Depleted of plasma, platelets and leukocytes

Platelet concentrate

Blood Products

AKA called random donor platelets.

Suspended in a small quantity of plasma derived from whole

blood within 8 hours of

collection.

Stored at a temperature of between +20 to +24 C with continuous agitation

Fresh frozen plasma

Blood Products

Non-cellular fluid portion of blood that has been separated from unit of whole blood within 6 to 8 hours of

collection, and has been

rapidly frozen and maintained

at all times at a temperature 30 C or lower

Cryosupernate

Blood Products

AKA cryo-poor plasma

The supernate plasma removed

during the preparation of cryoprecipitate.

Contains clotting factors

Cryoprecipitate

Blood Products

AKA cryoprecipitate pool, cryo, or pooled cryo

Contains the cryoglobulin fraction of plasma

Granulocyte concentrate

Blood Products

Made up of granulocytes collected through automation, i.e., apheresis

Leukocyte-depleted (filtered) red cell

Blood Products

Blood component that is obtained by removing most of the

plasma using 3rd generation filter

Leukopheresis

Hemapheresis

Only WBCs removed from donor

Plateletpheresis

Hemapheresis

Only platelet removed

Plasmapheresis

Hemapheresis

Only plasma removed

Red cell pheresis

Hemapheresis

Only red cells removed

Apheresis machine

Hemapheresis

An electronic instrument that takes blood from a donor, separates the desired component and returns the

remaining components to the donor

Plateletpheresis

Types of Apheresis

Platelet count of 150,000/uL;

48 hours required between donations, up to 24 times/year

Leukopheresis

Types of Apheresis

Not more than twice a week, 24 times/year

Plasmapheresis

Types of Apheresis

Every 4 weeks;

total protein, IgG and IgM monitored

Red cell pheresis

Types of Apheresis

Every 16 weeks

Adenine;

Citrate;

Dextrose;

Sodium biphosphate

Types of Anticoagulant

(?) - Used in ATP synthesis

(?) - chelates calcium to prevent coagulation

(?) - sugar to support RBC life

(?) - buffer to prevent decrease in pH

-CPD

-CP2D

-CPAD-1

Section 4

Promotion of Voluntary Blood Donation

Section 5

National Voluntary Blood Services Program

P25,000,000

P25,000,000

P20,000,000

Section 5 | National Voluntary Blood Services Program

Funds for this purpose shall be provided by the Government through:

a) PCSO: (?)

b) PAGCOR: (?)

c) Duty Free Shop: (?)

Section 6

Upgrading of Services and Facilities

Section 7

Phase-out of Commercial Blood Banks

2 years

Section 7 | Phase-out of Commercial Blood Banks

All commercial blood banks shall be phased out over a period of (?) AFTER effectivity of this Act,

extendable to a maximum period of by the Secretary

Section 8

Non-Profit Operation

Section 9

Regulation of Blood Services

Section 10

Importation of Blood Equipment, Blood Bags and Reagents

Section 11

Rules and Regulations

Section 12

Penalties

1-6 months;

P5,000-P50,000

Section 12 | Penalties

Blood bank/center collecting charges and fees greater than the maximum prescribed by the Department

Imprisonment:

Fine:

(Or both)

12 years and 1 day - 20 years

P50,000-P500,000

Section 12 | Penalties

Blood bank/center operating without LTO or fails to comply with standards

Imprisonment:

Fine:

(Or both)

10 years

Section 12 | Penalties

Dispensing, transfusing and failing to

dispose, within 48 hours, blood which have been proven contaminated with blood transfusion transmissible diseases

Imprisonment:

Section 13

Separability Clause

Section 14

Repealing Clause

Section 15

Effectivity

Fidel V. Ramos

Which president signed the R.A. 7719?

Jose De Venecia, Jr.

Speaker of the House of Representatives who signed the R.A. 7719?

Edgardo J. Angara

President of the Senate who signed the R.A. 7719?

Camilo L. Sabio

Secretary General House of Representatives who signed the R.A. 7719?

Edgardo E. Tumangan

Secretary of Senate who signed the R.A. 7719?

17-65 years old, less than 16 needs parents' consent

50 kgs/110 lbs

Female: >12.5 g/dL

Male: >3 g/dL

Donor Selection Area

Age:

Weight:

Hemoglobin:

>38%

Not to exceed 37.5 C or 99.5 F

50-100 beats/munute <50 accepted for athletes

Donor Selection Area

Hematocrit:

Temperature:

Pulse:

Multiple puncture marks

Donor Selection Area

Skin lesions: (indefinite deferral)

Permanent

Donor Deferral

• Diagnosed with AIDS

• Acquired viral Hepatitis after age of 11

• Taking tegison

• Diagnosed with Babesiosis & Chagas disease

• Men having sex with men (MSM)

• Blood-Associated diseases

• Intravenous drug abusers

• Hemophiliacs

• Confirmed positive for Hepatitis C antibody

• Confirmed positive for HTLV

3 years

Donor Deferral

Diagnosed and treated with malaria

12 months

Donor Deferral

• Close contact with hepatitis infected individual

• Received blood transfusion, or injections of blood or

products, organ, or tissue transplant

• Tattoo, piercing, acupuncture

• Received HB Ig

• Travelled to an endemic place for malaria

• Received rabies vaccine

• Risk of exposure to hepatitis

• Positive for Syphilis

• Sexual contact with a person with high risk to HIV infection

• Female with contact with bisexual male

• Treated for syphilis or gonorrhea

• Underwent major operation (includes dental surgery)

• Incarceration ni a jail (>72 hours)

6 weeks

Donor Deferral

• Following a delivery of a baby

• Philippines (9 months after birth)

2 months

Donor Deferral

• Previous blood donation

• Treatment for retinoids

1 month

Donor Deferral

• German measles vaccine (Rubella)

• Taking acutane (Isotretinoin), Proscar (Finasteride)

2 weeks

Donor Deferral

• Acute febrile illness (2-3 weeks)

• Measles (Rubeola), oral polio, mumps and yellow

fever vaccines, BCG, smallpox vaccination

5 days

Donor Deferral

Antibiotic for infection, oral antifungal

48 hours

Donor Deferral

Hemapheresis donation

12-24 hours

Donor Deferral

Recent alcohol intake

Heal/Cured

Donor Deferral

• Skin lesions

• Taking anti-TB drugs

May donate anytime if without vaccine associated symptoms

Donor Deferral

Killed vaccines and toxoids, DPT, Polio vaccine, Cholera, Hepa B, typhoid, paratyphoids, typhus, influenza

No deferral

Donor Deferral

• Aspirin (but cannot be used for platelet concentrate)

• 3 days deferral if needed for platelet concentrate

AO NO. 2008-0008

RULES AND REGULATIONS GOVERNING THE REGULATION BLOOD SERVICE FACILITY

May 2, 2008

AO NO. 2008-0008 date?

Francisco T. Duque III

DOH Secretary who signed AO NO. 2008-0008?